| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,922 | 22,942 | 58,656 | 84,695 | | Cost of Revenue | (2,079) | 12,501 | 22,440 | 468,653 | | | Gross Profit | 26,001 | 10,441 | 36,216 | (383,958) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (17,833) | 8,964 | 12,630 | 3,821 | | Non Recurring | 62,506 | 111,803 |
-
| 29,349 | | Others | 31,260 | 36,107 | 32,614 | 38,067 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (85,216) | (146,433) | (9,028) | (455,195) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26,746 | (14,285) | (4,662) | 6,265 | | Earnings Before Interest And Taxes | (89,978) | (164,335) | (12,943) | (437,237) | | Interest Expense | 10,729 | 15,883 | 17,074 | 14,239 | | Income Before Tax | (100,707) | (180,218) | (30,017) | (451,476) | | Income Tax Expense | 265 | 265 | (583) | (8,091) | | Minority Interest |
-
|
-
|
-
| 11,131 | | | | Net Income From Continuing Ops | (100,972) | (180,483) | (29,434) | (443,385) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (16,275) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (84,781) | (180,483) | (29,434) | (459,660) | | Preferred Stock And Other Adjustments | (12,046) | 8,166 | 3,880 |
-
| | | Net Income Applicable To Common Shares | ($96,827) | ($172,317) | ($25,554) | ($459,660) |
|
0.11% Nasdaq 
0.0001 (0.01%) 
Income Statement
